Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
- PMID: 17033622
- DOI: 10.1038/ng1902
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
Abstract
We identified constitutional truncating mutations of the BRCA1-interacting helicase BRIP1 in 9/1,212 individuals with breast cancer from BRCA1/BRCA2 mutation-negative families but in only 2/2,081 controls (P = 0.0030), and we estimate that BRIP1 mutations confer a relative risk of breast cancer of 2.0 (95% confidence interval = 1.2-3.2, P = 0.012). Biallelic BRIP1 mutations were recently shown to cause Fanconi anemia complementation group J. Thus, inactivating truncating mutations of BRIP1, similar to those in BRCA2, cause Fanconi anemia in biallelic carriers and confer susceptibility to breast cancer in monoallelic carriers.
Similar articles
-
Helicase-inactivating BRIP1 mutation yields Fanconi anemia with microcephaly and other congenital abnormalities.Cold Spring Harb Mol Case Stud. 2020 Oct 7;6(5):a005652. doi: 10.1101/mcs.a005652. Print 2020 Oct. Cold Spring Harb Mol Case Stud. 2020. PMID: 33028645 Free PMC article.
-
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832. Breast Cancer Res. 2011. PMID: 21356067 Free PMC article.
-
Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.J Hum Genet. 2008;53(7):579. doi: 10.1007/s10038-008-0285-z. Epub 2008 Apr 15. J Hum Genet. 2008. PMID: 18414782
-
BRIP1, a potential candidate gene in development of non-BRCA1/2 breast cancer.Front Biosci (Elite Ed). 2016 Jan 1;8(2):289-98. doi: 10.2741/E767. Front Biosci (Elite Ed). 2016. PMID: 26709662 Review.
-
Genetic predisposition to breast cancer: past, present, and future.Annu Rev Genomics Hum Genet. 2008;9:321-45. doi: 10.1146/annurev.genom.9.081307.164339. Annu Rev Genomics Hum Genet. 2008. PMID: 18544032 Review.
Cited by
-
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.Breast Cancer Res. 2013 Feb 28;15(1):R17. doi: 10.1186/bcr3392. Breast Cancer Res. 2013. PMID: 23448497 Free PMC article.
-
Disease-causing missense mutations in human DNA helicase disorders.Mutat Res. 2013 Apr-Jun;752(2):138-152. doi: 10.1016/j.mrrev.2012.12.004. Epub 2012 Dec 28. Mutat Res. 2013. PMID: 23276657 Free PMC article. Review.
-
Helicase-inactivating BRIP1 mutation yields Fanconi anemia with microcephaly and other congenital abnormalities.Cold Spring Harb Mol Case Stud. 2020 Oct 7;6(5):a005652. doi: 10.1101/mcs.a005652. Print 2020 Oct. Cold Spring Harb Mol Case Stud. 2020. PMID: 33028645 Free PMC article.
-
Novel role of BRCA1 interacting C-terminal helicase 1 (BRIP1) in breast tumour cell invasion.J Cell Mol Med. 2020 Oct;24(19):11477-11488. doi: 10.1111/jcmm.15761. Epub 2020 Sep 5. J Cell Mol Med. 2020. PMID: 32888398 Free PMC article.
-
Mutation and association analysis of GEN1 in breast cancer susceptibility.Breast Cancer Res Treat. 2010 Nov;124(1):283-8. doi: 10.1007/s10549-010-0949-1. Epub 2010 May 30. Breast Cancer Res Treat. 2010. PMID: 20512659 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous